Old Web
English
Sign In
Acemap
>
Paper
>
Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with Nivolumab
Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with Nivolumab
2017
Francesco Passiglia
Alessandro Perez
Angela Listì
Marta Castiglia
Emmanuela Musso
Chiara Ancona
Sergio Rizzo
Massimiliano Alù
Livio Blasi
Antonio Russo
Keywords:
Nivolumab
Circulating tumor DNA
Immunotherapy
Medicine
Cancer research
Biomarker (medicine)
predictive biomarker
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]